Stonebridge Capital Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-780
Closed -$30.5K 285
2023
Q3
$30.5K Buy
+780
New +$31.1K ﹤0.01% 428

Other funds holding BME

Stonebridge Capital Advisors's BME Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 780 shares — an estimated $30.5K sold.

Stonebridge Capital Advisors first reported a position in BME in Q3 2023 and held it in 1 quarter. The position peaked at $30.5K in Q3 2023. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 780 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $30.5K.
  • Stonebridge Capital Advisors first reported a position in BlackRock Health Sciences Trust in Q3 2023 and held it in 1 quarter.
  • Stonebridge Capital Advisors's BlackRock Health Sciences Trust position peaked at $30.5K in Q3 2023.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.